Grants and Contributions:
Title:
ARP - Increased omega-3 monoglyceride inflammation resolution activity
Agreement Number:
918477
Agreement Value:
$45,250.00
Agreement Date:
Dec 10, 2018 - Mar 29, 2019
Description:
The biological activity of omega-3 requires selective oxidation by lipoxygenase enzymes. In order to increase the activity of omega-3 monoglycerides, we want to premetabolize them with the help of a plant enzyme.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Sainte-Luce, Quebec, CA G0K 1P0
Reference Number:
172-2018-2019-Q4-918477
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
813879020
Recipient Type:
For-profit organization
Recipient's Legal Name:
Samuel C. Fortin Pharma inc.
Federal Riding Name:
Avignon--La Mitis--Matane--Matapédia
Federal Riding Number:
24006
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410